Daren R Ure

Title: Daren R Ure: Innovator in Fibrosis Treatment

Introduction

Daren R Ure is a notable inventor based in Edmonton, Canada. He has made significant contributions to the field of medicine, particularly in the treatment of fibrosis. With a total of 3 patents to his name, Ure's work focuses on innovative methods and compositions that aim to improve patient outcomes.

Latest Patents

One of Ure's latest patents involves the use of cyclosporine analogues for treating fibrosis. This patent discloses methods, compositions, and kits that are suitable for preventing, treating, or reversing fibrosis. The methods include administering a composition comprising a cyclosporine analogue, such as CRV431, or a pharmaceutically acceptable salt, solvate, or stereoisomer thereof. Another significant patent details cyclosporine analogue molecules modified at amino acids 1 and 3. These analogs of cyclosporin-A include modifications that enhance their affinity for cyclophilin, particularly cyclophilin-A, while reducing immunosuppressivity compared to traditional cyclosporin-A and its analogs.

Career Highlights

Throughout his career, Daren R Ure has worked with various companies, including Ciclofilin Pharmaceuticals Corp. and Contravir Pharmaceuticals, Inc. His innovative approaches have positioned him as a key player in the pharmaceutical industry, particularly in the development of treatments for fibrosis.

Collaborations

Ure has collaborated with notable professionals in his field, including Alexander Hegmans and Bruce W Fenske. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Daren R Ure's contributions to the field of fibrosis treatment through his innovative patents and collaborations highlight his importance as an inventor. His work continues to pave the way for new therapeutic options in medicine.